Democrats’ major drug pricing reforms clear a hurdle in the House

WASHINGTON — House Democrats Friday broke a monthslong logjam and advanced prescription drug pricing reform policies as part of a broader domestic spending package.

Despite a last-minute lobbying sprint by the pharmaceutical industry, the drug pricing deal Democrats announced earlier this month remained largely unchanged. The plan would allow Medicare to negotiate some drug prices, penalize drug makers that hike prices faster than inflation, and cap drug costs for seniors and patients who use insulin.